- 23830649OWN - NLMSTAT- MEDLINEDA  - 20130708DCOM- 20131021IS  - 1557-8232 (Electronic)IS  - 0749-0704 (Linking)VI  - 29IP  - 3DP  - 2013 JulTI  - Fulminant myocarditis.PG  - 465-83LID - 10.1016/j.ccc.2013.03.004 [doi]LID - S0749-0704(13)00021-3 [pii]AB  - Myocarditis is most often caused by a viral infection. Less common causes include      other infectious agents and autoimmune diseases. Fulminant myocarditis is an      unusual complication with a rapidly progressive course resulting in severe heart       failure and cardiogenic shock. Fulminant myocarditis should be treated with full       supportive care, using aggressive pharmacologic therapy and mechanical      circulatory support, because significant improvement in left ventricular function      will often occur. Cardiac transplantation is required in a small minority of      patients. Cardiac magnetic resonance imaging is becoming a frequently used      modality to aid in the diagnosis of myocarditis.CI  - Copyright (c) 2013 Elsevier Inc. All rights reserved.FAU - Ginsberg, FredricAU  - Ginsberg FAD  - Division of Cardiovascular Medicine, Cooper University Hospital, One Cooper      Plaza, Camden, NJ 08103, USA. Ginsberg-Fredric@CooperHealth.eduFAU - Parrillo, Joseph EAU  - Parrillo JELA  - engPT  - Journal ArticlePT  - ReviewPL  - United StatesTA  - Crit Care ClinJT  - Critical care clinicsJID - 8507720RN  - 0 (Anti-Infective Agents)RN  - 0 (Immunosuppressive Agents)SB  - IMMH  - Anti-Infective Agents/therapeutic useMH  - Assisted CirculationMH  - Diagnosis, DifferentialMH  - EchocardiographyMH  - ElectrocardiographyMH  - Heart Failure/drug therapy/*etiologyMH  - Heart TransplantationMH  - HumansMH  - Hypotension/*etiology/therapyMH  - Immunosuppressive Agents/adverse effects/standards/therapeutic useMH  - Intra-Aortic Balloon PumpingMH  - Magnetic Resonance ImagingMH  - *Myocarditis/complications/diagnosis/etiology/therapyMH  - Radiography, ThoracicMH  - Shock, Cardiogenic/*etiology/therapyMH  - Ventricular Function, Left/drug effects/*physiologyMH  - Virus Diseases/complicationsOTO - NOTNLMOT  - Extracorporeal membrane oxygenatorOT  - Fulminant myocarditisOT  - Immune mechanismsOT  - Inotropic agentsOT  - Lymphocytic myocarditisOT  - Mechanical circulatory supportOT  - Ventricular assist deviceEDAT- 2013/07/09 06:00MHDA- 2013/10/22 06:00CRDT- 2013/07/09 06:00AID - S0749-0704(13)00021-3 [pii]AID - 10.1016/j.ccc.2013.03.004 [doi]PST - ppublishSO  - Crit Care Clin. 2013 Jul;29(3):465-83. doi: 10.1016/j.ccc.2013.03.004.- 23830649own - nlmstat- medlineda  - 20130708dcom- 20131021is  - 1557-8232 (electronic)is  - 0749-0704 (linking)vi  - 29ip  - 3dp  - 2013 julti  - fulminant myocarditis.pg  - 465-83lid - 10.1016/j.ccc.2013.03.004 [doi]lid - s0749-0704(13)00021-3 [pii]ab  - myocarditis is most often caused by a viral infection. less common causes include      other infectious agents and autoimmune diseases. fulminant myocarditis is an      unusual complication with a rapidly progressive course resulting in severe heart       failure and cardiogenic shock. fulminant myocarditis should be treated with full       supportive care, using aggressive pharmacologic therapy and mechanical      circulatory support, because significant improvement in left ventricular function      will often occur. cardiac transplantation is required in a small minority of      patients. cardiac magnetic resonance imaging is becoming a frequently used      modality to aid in the diagnosis of myocarditis.ci  - copyright (c) 2013 elsevier inc. all rights reserved.fau - ginsberg, fredricau  - ginsberg fad  - division of cardiovascular medicine, cooper university hospital, one cooper      plaza, camden, nj 08103, usa. ginsberg-fredric@cooperhealth.edufau - parrillo, joseph eau  - parrillo jela  - engpt  - journal articlept  - reviewpl  - united statesta  - crit care clinjt  - critical care clinicsjid - 8507720rn  - 0 (anti-infective agents)rn  - 0 (immunosuppressive agents)sb  - immh  - anti-infective agents/therapeutic usemh  - assisted circulationmh  - diagnosis, differentialmh  - echocardiographymh  - electrocardiographymh  - heart failure/drug therapy/*etiologymh  - heart transplantationmh  - humansmh  - hypotension/*etiology/therapymh  - immunosuppressive agents/adverse effects/standards/therapeutic usemh  - intra-aortic balloon pumpingmh  - magnetic resonance imagingmh  - *myocarditis/complications/diagnosis/etiology/therapymh  - radiography, thoracicmh  - shock, cardiogenic/*etiology/therapymh  - ventricular function, left/drug effects/*physiologymh  - virus diseases/complicationsoto - notnlmot  - extracorporeal membrane oxygenatorot  - fulminant myocarditisot  - immune mechanismsot  - inotropic agentsot  - lymphocytic myocarditisot  - mechanical circulatory supportot  - ventricular assist deviceedat- 2013/07/09 06:00mhda- 2013/10/22 06:00crdt- 2013/07/09 06:00aid - s0749-0704(13)00021-3 [pii]aid - 10.1016/j.ccc.2013.03.004 [doi]pst - ppublishso  - crit care clin. 2013 jul;29(3):465-83. doi: 10.1016/j.ccc.2013.03.004.